FDA
approval
· 2018-09-18
FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
Summary
FDA approved a supplemental application for fentanyl transdermal submitted by SpecGx LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FENTANYL TRANSDERMAL (FENTANYL TRANSDERMAL)